SLAM
UTHR icon

Swiss Life Asset Management’s United Therapeutics UTHR Stock Holding History

Swiss Life Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57M Sell
12,132
-3,644
-23% -$2.05M 0.03% 406
2026
Q1 		$9.35M Buy
15,776
+4,043
+34% +$2.01M 0.05% 285
2025
Q4 		$5.72M Buy
11,733
+4,134
+54% +$1.93M 0.03% 381
2025
Q3 		$3.19M Sell
7,599
-7,031
-48% -$2.36M 0.02% 492
2025
Q2 		$4.2M Buy
14,630
+11,740
+406% +$3.51M 0.02% 415
2025
Q1 		$891K Sell
2,890
-9,205
-76% -$3.15M 0.01% 620
2024
Q4 		$4.27M Buy
12,095
+10,748
+798% +$3.95M 0.03% 339
2024
Q3 		$482K Sell
1,347
-3,587
-73% -$1.21M 0.01% 535
2024
Q2 		$1.57M Buy
4,934
+3,740
+313% +$990K 0.02% 412
2024
Q1 		$274K Sell
1,194
-379
-24% -$85.5K ﹤0.01% 521
2023
Q4 		$347K Buy
+1,573
New +$363K ﹤0.01% 609
2018
Q4 		– Sell
-16,549
Closed -$2.12M – 457
2018
Q3 		$2.12M Buy
16,549
+11,195
+209% +$1.38M 0.03% 307
2018
Q2 		$606K Buy
5,354
+1,168
+28% +$128K 0.01% 414
2018
Q1 		$470K Buy
+4,186
New +$532K 0.01% 417
2017
Q2 		– Sell
-2,262
Closed -$306K – 484
2017
Q1 		$306K Sell
2,262
-6,221
-73% -$942K 0.01% 428
2016
Q4 		$1.22M Buy
8,483
+4,737
+126% +$605K 0.04% 223
2016
Q3 		$441K Sell
3,746
-1,091
-23% -$131K 0.02% 378
2016
Q2 		$511K Buy
+4,837
New +$540K 0.02% 238
2015
Q4 		– Sell
-1,700
Closed -$223K – 364
2015
Q3 		$223K Buy
+1,700
New +$273K 0.01% 291

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Swiss Life Asset Management's UTHR Position: Q2 2026 in Review

Swiss Life Asset Management reduced its United Therapeutics (UTHR) stake by 23% in Q2 2026, selling an estimated $2.05M and leaving 12,132 shares worth $6.57M. The position accounts for 0.03% of the portfolio, ranked #406.

Swiss Life Asset Management first reported a position in UTHR in Q3 2015 and has held it in 19 quarters since. The position peaked at $9.35M in Q1 2026. 550 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Swiss Life Asset Management held 12,132 shares of United Therapeutics worth $6.57M as of Q2 2026.
  • Swiss Life Asset Management sold 3,644 United Therapeutics shares in Q2 2026, an estimated $2.05M.
  • United Therapeutics made up 0.03% of Swiss Life Asset Management's portfolio in Q2 2026, its #406 holding.
  • Swiss Life Asset Management first reported a position in United Therapeutics in Q3 2015 and has held it in 19 quarters since.
  • Swiss Life Asset Management's United Therapeutics position peaked at $9.35M in Q1 2026.
  • 550 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.